0001104659-22-082020.txt : 20220722
0001104659-22-082020.hdr.sgml : 20220722
20220722163141
ACCESSION NUMBER: 0001104659-22-082020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220720
FILED AS OF DATE: 20220722
DATE AS OF CHANGE: 20220722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoberman Kenneth
CENTRAL INDEX KEY: 0001573722
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 221100261
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
tm2221660-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-07-20
0
0001001316
TG THERAPEUTICS, INC.
TGTX
0001573722
Hoberman Kenneth
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
Common Stock
2022-07-20
4
A
0
43732
0
A
222685
D
Reflects a grant of restricted shares that will vest on June 15, 2023.
Includes shares of restricted Common Stock, which vest over various time periods.
/s/ Kenneth Hoberman
2022-07-22